Thursday, August 27, 2009

Neuland Lab begins peptides production, starts new High Potent API facility

Neuland Laboratories, a reliable global provider of APIs and other essential drug discovery and development support services today announced successfully commencement of manufacturing of peptides blocks by successfully commercializing the production of Fmoc Pseudoproline Dipeptides and other building blocks in India and the US subsidiary.


The details can be read here.

No comments: